Add BrightSurf on Google Email

Science News Archive March 2010 - Page 23


Page 23 of 27

'Match' Madness: Picking upsets a losing strategy

Research from Indiana University and the University of Wyoming found that picking lower-seed winners is a good strategy, while upsets are no better than chance. Experts advise against relying on intuition or favorite colors, as this approach often leads to sabotaging efforts.

SourceIndiana University·JournalJournal of Applied Social Psychology·DateMar 4, 2010

Scientists find new form of prion disease that damages brain arteries

Scientists have discovered a new form of prion disease that causes brain artery damage, distinct from the typical sponge-like brain deterioration. The study may hold clues for treating Alzheimer's disease, as researchers found that removing a specific anchor from prion protein could prevent plaque accumulation and block fluid drainage.

Vigilance needed in nanotechnology

Researchers have developed a methodology to measure nanoparticles in chicken embryos, shedding light on their potential effects on human health. The study's findings will inform regulatory approaches and help make nanotechnology more sustainable.

SourceUniversity of Calgary·JournalChemical Physics Letters·DateMar 3, 2010

Early test for a killer of the sickest

Researchers at Duke University have developed a new gene-expression test that can detect Candida fungal infections in patients. The test measures how a patient's genes respond to the infection and has shown promising results in mice, indicating it could be an early detector of life-threatening candidemia.

SourceDuke University Medical Center·JournalScience Translational Medicine·DateMar 3, 2010

25th anniversary of anti-AIDS drugs

The 25th anniversary of antiretroviral drug development is celebrated with a milestone Special Issue in Elsevier's Antiviral Research journal, featuring review articles from key players in the field. HIV-1 has gone from being an 'inherently untreatable' agent to one eminently susceptible to approved therapies.

SourceElsevier·JournalAntiviral Research·DateMar 3, 2010